Business
Elevation Point Wealth Partners Reduces Oracle Holdings by 35.4%
Elevation Point Wealth Partners LLC has significantly reduced its stake in Oracle Corporation, selling 6,030 shares during the second quarter of 2023. This decision results in a 35.4% decrease in their holdings, leaving the institutional investor with 11,010 shares valued at approximately $2.4 million as of the end of June 2023. The details of this transaction were disclosed in a recent filing with the Securities and Exchange Commission (SEC).
A series of other institutional investors have also adjusted their positions in Oracle recently. Notably, Nuveen LLC acquired a new stake valued at $732.7 million during the first quarter. Vanguard Group Inc. increased its holdings by 2.2%, now owning over 160.9 million shares worth approximately $22.5 billion after purchasing an additional 3.5 million shares. Meanwhile, Mitsubishi UFJ Asset Management Co. Ltd. boosted its stake by an impressive 79.2%, acquiring nearly 2.1 million shares, now valued at around $648.6 million.
In total, around 42.44% of Oracle’s stock is currently owned by institutional investors and hedge funds, reflecting significant institutional interest in the company.
Market Analysts’ Perspectives
Several research analysts have recently evaluated Oracle’s stock performance. Sanford C. Bernstein raised their target price from $363.00 to $364.00, maintaining an “outperform” rating. Morgan Stanley also increased their price objective from $246.00 to $320.00, assigning an “equal weight” rating. Meanwhile, Royal Bank of Canada reiterated a “sector perform” rating with a target price of $310.00.
In contrast, Rothschild & Co Redburn initiated coverage with a “sell” rating and a target of $175.00. Overall, the consensus among analysts indicates a “Moderate Buy” rating, with an average price target of $324.89.
Oracle’s Stock Performance and Financial Health
As of October 23, 2023, shares of Oracle Corporation (NYSE: ORCL) opened at $205.29. The company has a market capitalization of $585.2 billion and reported a P/E ratio of 47.52. Oracle’s stock has fluctuated significantly over the past year, with a low of $118.86 and a high of $345.72.
On September 9, 2023, Oracle announced its quarterly earnings, reporting an EPS of $1.47, which fell slightly short of analysts’ expectations at $1.48. The company generated $14.93 billion in revenue, missing the forecast of $15.04 billion. Despite this, Oracle reported a year-on-year revenue increase of 12.2%.
Oracle has provided guidance for Q2 2026, estimating an EPS between $1.270 and $1.310. Analysts are projecting a total of $5 in earnings per share for the current fiscal year.
In addition, the company has declared a quarterly dividend of $0.50 per share, which was paid on October 23, 2023. This dividend represents an annualized payout of $2.00 and a yield of 1.0%. The current payout ratio stands at 46.3%.
Recent insider trading activity has also drawn attention, with Stuart Levey, Executive Vice President, selling 19,758 shares at an average price of $300.00, totaling $5.93 million. Following this transaction, Levey holds 18,429 shares valued at approximately $5.53 million. Similarly, Michael D. Sicilia sold 33,845 shares at about $321.16, worth around $10.87 million.
In total, corporate insiders have sold over 204,254 shares valued at approximately $60.2 million in the past 90 days, with insiders currently holding 40.9% of Oracle’s stock.
As Oracle continues to adapt to the evolving technology landscape, the institutional interest and analysts’ evaluations suggest a complex but optimistic outlook for the enterprise software giant.
-
Science9 months agoUniversity of Hawaiʻi Joins $25.6M AI Project to Enhance Disaster Monitoring
-
Health8 months agoMajor Grant Enhances Cancer Care and Research in Hawaiʻi
-
Top Stories9 months agoJoleen Chaney, Beloved Journalist, Passes Leaving Lasting Legacy
-
World7 months agoSan Francisco’s SFO to Welcome 16 Airlines with Nonstop Flights to Europe in 2026
-
Business8 months agoGoldman Sachs Unveils 2026 Catalyst Playbook for Biotech Investors
-
Business7 months agoDiscover Top Business Smartphones for Professionals in 2026
-
Top Stories9 months agoUrgent Update: Tom Aspinall’s Vision Deteriorates After UFC 321
-
Lifestyle9 months agoTexas Roadhouse Honors Veterans with Free Meal Vouchers
-
Entertainment8 months agoCD Projekt Red Confirms No Release for The Witcher 4 in 2026
-
Top Stories10 months agoAI Disruption: AWS Faces Threat as Startups Shift Cloud Focus
-
Health10 months agoMIT Scientists Uncover Surprising Genomic Loops During Cell Division
-
Entertainment10 months agoDiscover the Full Map of Pokémon Legends: Z-A’s Lumiose City
